slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8.070 KRW | +1,13% | +0,12% | -14,87% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Anti-cancer Drugs
100,0
%
| 0 | nan % | 162 | 100,0 % | - |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Singapore
100,0
%
| 0 | nan % | 162 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
So-Yeon Park
CEO | Chief Executive Officer | 61 | - |
Lai Wat Tay
DFI | Director of Finance/CFO | 68 | - |
Jin Woo Kim
COO | Chief Operating Officer | 60 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lai Wat Tay
DFI | Director of Finance/CFO | 68 | - |
So-Yeon Park
CEO | Chief Executive Officer | 61 | - |
Eui-Kyung Lee
BRD | Director/Board Member | 65 | - |
Jin Woo Kim
COO | Chief Operating Officer | 60 | - |
Seung Joo Oh
BRD | Director/Board Member | 48 | - |
Kue Ho Bang
BRD | Director/Board Member | 61 | 15-06-23 |
Kok Fatt Lee
BRD | Director/Board Member | 51 | - |
Kyung Hee Jeon
BRD | Director/Board Member | 56 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 019 231 | 0 | 0 | - |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
PRESTIGE BIOLOGICS CO., LTD. 24.73% | 15 206 560 | 24.73% | 45 330 299 $ |
Bedrijfsgegevens
Prestige BioPharma Ltd.
04-24/28 Nucleos South Building 21 Biopolis Road
138567, Singapore
+
http://www.prestigebiopharma.comSector
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,87% | 72,01 mln. | |
-2,31% | 92,59 mld. | |
+3,16% | 41,43 mld. | |
-11,10% | 33,49 mld. | |
+53,99% | 25,06 mld. | |
-9,41% | 12,77 mld. | |
-12,25% | 11,58 mld. | |
-44,00% | 11,35 mld. | |
+5,77% | 8,97 mld. | |
-5,26% | 8,3 mld. |
- Beurs
- Aandelen
- Koers A950210
- Onderneming Prestige BioPharma Limited